Higher infused CD34+ hematopoietic stem cell dose correlates with earlier lymphocyte recovery and better clinical outcome after autologous stem cell transplantation in non‐Hodgkin's lymphoma - Concepedia

Concepedia

Publication | Closed Access

Higher infused CD34+ hematopoietic stem cell dose correlates with earlier lymphocyte recovery and better clinical outcome after autologous stem cell transplantation in non‐Hodgkin's lymphoma

47

Citations

39

References

2009

Year

Dok Hyun Yoon, Byeong Seok Sohn, Geundoo Jang, Eun Kyoung Kim, Byung Woog Kang, Chul Kim, Jeong‐Eun Kim, Shin Kim, Dae Ho Lee, Jung‐Shin Lee,

Abstract

These data suggest that infused CD34+ cell count is predictive of kinetics of lymphocyte recovery after ASCT and is an independent prognostic factor for OS and EFS after ASCT in patients with NHL.

References

	Year	Citations

Page 1